IL6 and congenital rubella syndrome: As monocytes and macrophages are primary sources of IL-6, IL-1, and nitric oxide (NO), contributing to CRS, the integration of ASCT with CAR-T may potentially reduce the incidence of CRS and CRES following CAR-T cell infusion [20,21].